Cite
Lamprou I, Tsolou A, Kakouratos C, et al. Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine. Med Oncol. 2021;38(10):116doi: 10.1007/s12032-021-01566-y.
Lamprou, I., Tsolou, A., Kakouratos, C., Mitrakas, A. G., Xanthopoulou, E. T., Kassela, K., Karakasiliotis, I., Zois, C. E., Giatromanolaki, A., & Koukourakis, M. I. (2021). Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine. Medical oncology (Northwood, London, England), 38(10), 116. https://doi.org/10.1007/s12032-021-01566-y
Lamprou, Ioannis, et al. "Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine." Medical oncology (Northwood, London, England) vol. 38,10 (2021): 116. doi: https://doi.org/10.1007/s12032-021-01566-y
Lamprou I, Tsolou A, Kakouratos C, Mitrakas AG, Xanthopoulou ET, Kassela K, Karakasiliotis I, Zois CE, Giatromanolaki A, Koukourakis MI. Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine. Med Oncol. 2021 Aug 19;38(10):116. doi: 10.1007/s12032-021-01566-y. PMID: 34410522; PMCID: PMC8374126.
Copy
Download .nbib